H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price passed below its 50-day moving average during trading on Thursday. The stock has a 50-day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares trading hands.
H. Lundbeck A/S Trading Down 0.0%
The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The business has a 50 day moving average of $22.00 and a 200-day moving average of $22.00. The firm has a market capitalization of $21.91 billion, a P/E ratio of 25.00 and a beta of 0.68.
About H. Lundbeck A/S
H. Lundbeck A/S is a Denmark-based pharmaceutical company focused on researching, developing and commercializing treatments for disorders of the brain. Its activities center on neuroscience, with therapeutic areas including depression, schizophrenia, migraine, Alzheimer’s disease, Parkinson’s disease and alcohol dependence.
The company’s portfolio includes prescription medicines such as Rexulti (brexpiprazole) for certain psychiatric disorders, Trintellix (vortioxetine) for major depressive disorder and Vyepti (eptinezumab) for migraine prevention.
Featured Stories
- Five stocks we like better than H. Lundbeck A/S
- Bloom Energy Just Reported—Its Biggest Order Is Still Waiting on a Pipeline
- Why Western Digital’s AI Storage Boom Defies the Chip Sell-Off
- Grand Canyon Education Strengthens Its Outlook, But Wall Street Remains Divided
- Amex Stock Slides on Job Cuts, But the Real Story Is Macro
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
